PAUL C GRINT
CIK 1236548 · Chief Executive Officer · last filed 2024-07-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.35M
Companies
4
Total Filings
29
Lifetime Open-Market Net
-$1.46M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IKT | Director | — | $1.67 | — | $0 | 5 | 2024-07-18 |
| Armata Pharmaceuticals, Inc. (APHB) Delisted | Chief Executive Officer | 599 | — | — | $0 | 3 | 2017-12-12 |
| Regulus Therapeutics Inc. (RGLS) Delisted | President & CEO | — | $8.16 | — | $0 | 8 | 2017-02-23 |
| ILMN | Director | 8,365 | $160.97 | $1.35M | -$1.46M | 13 | 2013-01-07 |
Recent Filings · Page 2 of 3
29 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-05 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-06 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-11-09 | Armata Pharmaceuticals, Inc. (APHB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-26 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-04 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-10-22 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-01-07 | ILMN | Grant (A) | +295 | $0 | EDGAR |
| 2012-10-03 | ILMN | Grant (A) | +343 | $0 | EDGAR |
| 2012-07-05 | ILMN | Grant (A) | +333 | $15.0K | EDGAR |
| 2012-04-20 | ILMN | Grant (A) | +1,440 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.